NO176234C - Fremgangsmåte for inaktivering av patogener i et biologisk eller et farmasöytisk materiale - Google Patents

Fremgangsmåte for inaktivering av patogener i et biologisk eller et farmasöytisk materiale

Info

Publication number
NO176234C
NO176234C NO882242A NO882242A NO176234C NO 176234 C NO176234 C NO 176234C NO 882242 A NO882242 A NO 882242A NO 882242 A NO882242 A NO 882242A NO 176234 C NO176234 C NO 176234C
Authority
NO
Norway
Prior art keywords
aqueous solution
biological
pharmaceutical material
inactivating pathogens
primary
Prior art date
Application number
NO882242A
Other languages
English (en)
Norwegian (no)
Other versions
NO882242D0 (no
NO176234B (no
NO882242L (no
Inventor
Fred Feldman
Mark S Klekamp
Michael E Hrinda
Arthur B Shaw
Sudhish Chandra
Original Assignee
Armour Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armour Pharma filed Critical Armour Pharma
Publication of NO882242D0 publication Critical patent/NO882242D0/no
Publication of NO882242L publication Critical patent/NO882242L/no
Publication of NO176234B publication Critical patent/NO176234B/no
Publication of NO176234C publication Critical patent/NO176234C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO882242A 1987-05-22 1988-05-20 Fremgangsmåte for inaktivering av patogener i et biologisk eller et farmasöytisk materiale NO176234C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5292687A 1987-05-22 1987-05-22

Publications (4)

Publication Number Publication Date
NO882242D0 NO882242D0 (no) 1988-05-20
NO882242L NO882242L (no) 1988-11-23
NO176234B NO176234B (no) 1994-11-21
NO176234C true NO176234C (no) 1995-03-01

Family

ID=21980809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882242A NO176234C (no) 1987-05-22 1988-05-20 Fremgangsmåte for inaktivering av patogener i et biologisk eller et farmasöytisk materiale

Country Status (11)

Country Link
EP (1) EP0292003B1 (ja)
JP (2) JP2605102B2 (ja)
AT (1) ATE103185T1 (ja)
AU (1) AU606159B2 (ja)
CA (1) CA1337688C (ja)
DE (1) DE3888571T2 (ja)
ES (1) ES2061554T3 (ja)
FI (1) FI95778C (ja)
IL (1) IL86417A (ja)
NO (1) NO176234C (ja)
NZ (1) NZ224740A (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619565A1 (de) * 1986-06-11 1987-12-17 Behringwerke Ag Verfahren zur herstellung einer pasteurisierten immunglobulinpraeparation
EP0440509A3 (en) * 1990-02-02 1991-12-18 Common Services Agency Novel cell growth medium components and process for producing same
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
AT399818B (de) * 1992-04-24 1995-07-25 Immuno Ag Verfahren zur herstellung einer hochgereinigten virussicheren faktor viii-präparation
AU6653094A (en) * 1992-12-16 1994-07-04 Immuno Aktiengesellschaft Process for preparing a virus-safe biological composition
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
HRP940645A2 (en) * 1993-10-06 1996-12-31 Immuno Ag Process for virus deactivation in the presence of polyalkylene glycol and the pharmaceutical preparation thus obtained
US5616693A (en) * 1996-07-01 1997-04-01 Alpha Therapeutic Corporation Process for seperating alpha-1-proteinase inhibitor from COHN IV1 +1V4 paste
DE60035260T2 (de) 1999-02-22 2007-10-18 The University Of Connecticut, Farmington Neue albuminfreie faktor viii formulierungen
WO2006131515A2 (en) * 2005-06-06 2006-12-14 Novo Nordisk A/S Stabilised il-21 compositions
DE102006008613A1 (de) 2006-02-24 2007-08-30 Dade Behring Marburg Gmbh Stabilisierte Zubereitungen von Serin-Endopeptidasen, deren Herstellung und Verwendung
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53142593A (en) * 1977-12-12 1978-12-12 Green Cross Corp:The Stabilization of urokinase by heating
EP0035204B2 (en) * 1980-03-05 1991-05-22 Miles Inc. Pasteurized therapeutically active protein compositions
JPS56135418A (en) * 1980-03-27 1981-10-22 Green Cross Corp:The Heat treatment of aqueous solution containing 8 factor of coagulation of blood derived from human
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
US4379085A (en) * 1982-05-14 1983-04-05 American National Red Cross Heat stabilization of plasma proteins
US4470968A (en) * 1983-01-13 1984-09-11 Miles Laboratories, Inc. Pasteurized therapeutically active blood coagulation factor concentrates
JPS59134730A (ja) * 1983-01-20 1984-08-02 Green Cross Corp:The 血液凝固第８因子の加熱処理法
CA1213827A (en) * 1983-04-29 1986-11-12 Ricardo H. Landaburu Process for pasteurizing fibronectin
JPH0669961B2 (ja) * 1984-09-25 1994-09-07 株式会社ミドリ十字 免疫グロブリンの加熱処理方法
JPS61189228A (ja) * 1985-02-19 1986-08-22 Nippon Sekijiyuujishiya 血液凝固第８因子製剤の製法
JPH0825902B2 (ja) * 1985-02-21 1996-03-13 株式会社ミドリ十字 γ−グロブリンの加熱処理方法
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
JPS6289628A (ja) * 1985-09-11 1987-04-24 Green Cross Corp:The 人フイブリノゲン製剤の加熱処理法
JPS6281327A (ja) * 1985-10-04 1987-04-14 Green Cross Corp:The 人トロンビン製剤の加熱処理方法

Also Published As

Publication number Publication date
IL86417A0 (en) 1988-11-15
NO882242D0 (no) 1988-05-20
JP2605102B2 (ja) 1997-04-30
JPS649937A (en) 1989-01-13
JPH09118634A (ja) 1997-05-06
IL86417A (en) 1992-09-06
NO176234B (no) 1994-11-21
ES2061554T3 (es) 1994-12-16
AU1664288A (en) 1988-11-24
FI95778C (fi) 1996-03-25
DE3888571T2 (de) 1994-08-11
EP0292003A2 (en) 1988-11-23
ATE103185T1 (de) 1994-04-15
JP2879427B2 (ja) 1999-04-05
FI882387A (fi) 1988-11-23
NO882242L (no) 1988-11-23
FI95778B (fi) 1995-12-15
EP0292003A3 (en) 1990-06-13
EP0292003B1 (en) 1994-03-23
DE3888571D1 (de) 1994-04-28
FI882387A0 (fi) 1988-05-20
CA1337688C (en) 1995-12-05
NZ224740A (en) 1990-01-29
AU606159B2 (en) 1991-01-31

Similar Documents

Publication Publication Date Title
NO176234C (no) Fremgangsmåte for inaktivering av patogener i et biologisk eller et farmasöytisk materiale
LU84486A1 (fr) Nouveau derive de l'acide 2-(p-isobutylphenyl)propionique,son procede de preparation et son application en therapeutique
HUT44793A (en) Process for production of 19-nor or 19-nor-d-homo stereoids substituated in position 11-beta by alkinylphenil group and medical preparatives containing them as active substance
ES8106407A1 (es) Procedimiento para el tratamiento de superficies hidrofobas
DE3852116D1 (de) Herstellung von Proteinen in aktiver Form.
DK162393C (da) Polysvovlsyreestere af bis-hexonsyreamider og derivater deraf samt fremgangsmaade til fremstilling af samme
ATE58918T1 (de) Verfahren zur herstellung von kristalliner larabinose.
PT90362A (pt) Metodo para o tratamento de doencas muco-epiteliais e da pele em mamiferos que utiliza acidos 4-quinolinocarboxilicos e seus derivados e processo para a preparacao de composicoes farmaceuticas que contem os mesmos compostos
FR2607517B2 (fr) Vecteurs d'expression de variants de l'hirudine dans les levures, procede et produit obtenu
IL68255A0 (en) Actinomycete fungus strains and methods for the control of fungus diseases in plants using the same
DE3787575D1 (de) Verfahren und vorrichtung zum herstellen von float-glas.
DE3779913D1 (de) Verdickte bleichmittel und verfahren zu deren herstellung.
DE3171100D1 (en) Process for separation of products containing propolis and products containing propolis
DE3481525D1 (de) Herstellung von plasmid-dns und produkte davon.
ES524890A0 (es) Metodo de produccion de composiciones que contienen globulina gamma
ES2072331T3 (es) Procedimiento para la descontaminacion de cultivos celulares que contienen micoplasmas.
ATE155542T1 (de) Verfahren zum entfärben und bleichen von altpapier
DE3574675D1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.
RO80029A2 (ro) Derivat de acid nicotinic si procedeu de preparare a acestuia
PT72567A (fr) Procede de preparation de derives du cycloheptindolol et de leurs sels avec les acides
MX164571B (es) Proceso para le eliminacion del arsenico en la elaboracion del acido fluorhidrico
FR2624524B1 (fr) Procede de traitement hydrometallurgique de solution de matieres galliferes
RO88357A2 (ro) Derivati ai acidului 7-aminodezacetoxi-cefalosporanic si procedeu de preparare a acestora
AU7645881A (en) Method for treatment of disease in plant material
RO95736A2 (ro) Procedeu de control biologic al oualor in procesul de incubatie

Legal Events

Date Code Title Description
MK1K Patent expired